Health-care shares were fairly flat in pre-market trade
In health-care stocks news, Bristol-Myers Squibb Company (
) shares were up 1.6% pre-bell after the pharmaceutical company
posted Q2 adjusted earnings that beat forecasts, while revenue came
The company reported GAAP EPS fell 38% to $0.20, while non-GAAP
EPS rose 9% to $0.48. On an adjusted basis, that beats analysts'
forecasts for $0.44, according to Capital IQ.
And, Agenus (
) shares were higher nearly 8% in recent pre-market trade after
reporting a Q2 loss that wasn't as large as had been expected.
AGEN is trading in the lower half of the 52-week range between
$2.27 and $5.27.
The immuno-oncology company said its Q2 loss was $7.7 million or
$0.12 per share compared to a loss of $11.2 million or $0.40 the
year earlier, and was better than the $0.17 loss expected by
analysts polled by Capital IQ.
Also, CryoLife (
) has reported Q2 EPS that beat the Street view but total revenues
that missed. The company has also lowered full-year revenue
guidance. CRY was steady at $9.16 with a 52-week range of $6.01 to
Finally, Celgene (
) was down about 1% after it reported Q2 results that beat the
Street view on both EPS and total revenue and has raised guidance
for full-year results.
The pharmaceutical company has reported Q2 EPS of $0.90, up from
$0.76 in Q2 2013 and topping analyst estimates of $0.89. Total
revenues of $1.87 billion were up from $1.59 billion in Q2 2013 and
surpassed analyst expectations of $1.85 billion.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.